New drugs for Parkinson's disease: The regulatory and clinical development pathways in the United States.
about
New drugs for Parkinson's disease: The regulatory and clinical development pathways in the United States.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
New drugs for Parkinson's dise ...... pathways in the United States.
@en
New drugs for Parkinson's dise ...... pathways in the United States.
@nl
type
label
New drugs for Parkinson's dise ...... pathways in the United States.
@en
New drugs for Parkinson's dise ...... pathways in the United States.
@nl
prefLabel
New drugs for Parkinson's dise ...... pathways in the United States.
@en
New drugs for Parkinson's dise ...... pathways in the United States.
@nl
P2860
P356
P1433
P1476
New drugs for Parkinson's dise ...... pathways in the United States.
@en
P2093
Russell Katz
P2860
P356
10.1002/MDS.27220
P407
P577
2017-12-04T00:00:00Z